Brain Tumor Cells Made Increasingly Receptive To Radiation Therapy

Researchers from the Duke University have deciphered the way in which stem cells present in the malignant brain cancer glioma could most aptly defend against radiation therapy. By employing a drug for blocking a certain signalling pathway in such cancer stem cells, they could annihilate greater numbers of glioma cells with radiation in a lab trial.

The research work endeavoured at building off the previous research that revealed the greater resistance of cancer stem cells to the effects of radiation therapy in comparison to the other cancer cells.

The Duke researchers recognized a well-known signalling pathway known as Notch as the possible cause for the enhanced resistance. Notch additionally operated in healthy stem cells where it is vital for inter cell communication that manages cell proliferation and separation processes. The study was printed in the end of November edition in the journal ‘Stem Cells’.

Jialiang Wang, Ph.D., the lead author and a research associate at the Duke Division of Surgery Sciences and the Duke Translational Research Institute stated that this discovery has made the Notch pathway a striking drug objective and the appropriate drug could be capable of halting the offenders, the glioma stem cells.

Wang mentioned that stem cells present in a cancer are the basis of cancer cell propagation. Cancer stem cells numbering in hundreds could swiftly turn into a million.

The researchers from Duke in partnership with a team headed by Dr. Jeremy Rich, Cleveland Clinic, employed drugs known as gamma-secretase inhibitors which targeted a key enzyme that was engaged in Notch signalling pathway on gliomas in a laboratory setting. Such inhibitors are under study by many researchers for their capacity in combating tumors in whom Notch is anomalously triggered like in leukemia and tumors of the breast and brain.

Dr. Bruce Sullenger, the senior author and the Vice Chair for Research in Duke and the Professor of Surgery, Dorothy W.Beard expounded that in their study gamma-secretase inhibitors solely were able to only somewhat slow down the tumour cell proliferation. However, when they observed these molecules in combination with radiation at clinically pertinent dosages, this blend lead to enormous cell fatalities in the tumors and considerably lowered survival in glioma stem cells. Such findings mostly associate with improved tumor control.

Wang stated that in-progress clinical trials are evaluating gamma-secretase inhibitors as individual therapy for breast and brain tumors. Their study indicates that Notch inhibition employing such drugs would offer noteworthy remedial advantages when coalesced with radiotherapy. Wang was hopeful that imminent research would study this coalesced therapy in this susceptible patient populace. Wang stated that more effectual radiation could be achievable when they could halt Notch signalling in the tumor stem cells.

Popularity: 4% [?]